Gene therapy of melanoma pulmonary metastasis by intramuscular injection of plasmid DNA encoding tissue inhibitor of metalloproteinases-1

Cancer Gene Therapy

Volumn 9, Issue 2, 2002, Pages 126-132

  Shi, Yufei ^a   Parhar, Ranjit S ^a   Zou, Minjing ^a   Al Mohanna, Futwan A ^a   Paterson, Malcolm C ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Cytokine; Gene therapy; Matrix metalloproteinase; Melanoma; Metastasis; Proteinase inhibitor; TIMP

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 2; PLACEBO; PLASMID DNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER INVASION; CANCER PREVENTION; CANCER SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; FEMALE; GENE THERAPY; GENE TRANSFER; LUNG METASTASIS; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALIA;

ANIMALS; CELLS, CULTURED; CYTOKINES; DNA; DRUG THERAPY, COMBINATION; FEMALE; GENE THERAPY; HUMANS; INJECTIONS, INTRAMUSCULAR; INTERLEUKIN-1; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; PLASMIDS; PROTEASE INHIBITORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFECTION;

EID: 0036171282     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700426     Document Type: Article

References (39)

1. The hallmarks of cancer
2. Molecular insights into cancer invasion: Strategies for prevention and intervention
3. Interactions between tumor cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer
4. Tumor cell interactions with the extracellular matrix during invasion and metastasis
5. Matrix metalloproteinases
6. Insights into MMP-TIMP interactions
7. Metastastic potential correlates with enzymatic degradation of basement membrane collagen
8. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials
9. Metalloproteinases and cancer invasion and metastasis
10. Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential
11. Direct evidence linking MMP-9 (92 kDa gelatinase/collagenase) expression to the metastatic phenotype in transformed rat embryo cells
12. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4
13. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1
14. Engineering of selective TIMPs
15. Residue 2 of TIMP-1 is a major determinant of affinity and specificity for matrix metalloproteinases but effects of substitutions do not correlate with those of the corresponding P1′ residue of substrate
16. Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lymphomas
17. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas
18. Immunological quantitation of levels of tissue inhibitor of metalloproteinase-1 in human colon cancer
19. Tissue inhibitor of metalloproteinases-1 (TIMP-1) mRNA is elevated in advanced stages of thyroid carcinoma
20. Adoptive immunotherapy after hematopoietic stem cell transplantation
21. Cure of B16F10 melanoma lung metastasis in mice by chronic indomethacin therapy combined with repeated rounds of IL-2: Characteristics of killer cells generated in situ
22. Biological behavior of malignant melanoma cells correlated to their survival in vivo
23. Effects of cytokine-mediated modulation of nm23 expression on the invasion and metastatic behavior of B16Fl0 melanoma cells
24. A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon α
25. Potential applications of tissue inhibitor of metalloproteinase (TIMP) overexpression for cancer gene therapy
26. Host TIMP-1 overexpression confers resistance to experimental brain metastasis of a fibrosarcoma cell line
27. Transgenic TIMP-1 inhibits simian virus 40T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis
28. Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue
29. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases
30. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16F10 melanoma cells
31. Matrix metalloproteinase inhibitors
32. Synthetic inhibitors of matrix metalloproteinases
33. Phase 1 and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies
34. Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors
35. Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-beta1
36. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: Involvement of membrane-associated cytokines
37. Reprogramming of TIMP-1 and TIMP-3 expression profiles in brain microvascular endothelial cells and astrocytes in response to proinflammatory cytokines
38. Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3
39. Immunoprevention of cancer: Is the time ripe?